With nAmbition, JPK strengthens its leading position in the field of NanoBiotechnology. JPK’s CTO Torsten Jähnke says “We are very happy that we could win Dr. Jens Struckmeier as chief technology officer for nAmbition. He has outstanding expertise in SPM technology - especially for biological applications - and will guide nAmbition to be the technology leader in this field.”
The technology platform from nAmbition has a big impact on the life sciences, especially in medicine and pharmaceutical research.
nAmbition and TU Dresden have acquired one of the biggest technology grants in the history of the funding of NanoBiotechnology in Germany, with more than 3 Mio € from the Innoregio and BioMeT initiative of the BMBF.
JPK Instruments AG together with partners from Dresden Fonds GmbH, Kajak GmbH and tbg is guiding nAmbition to become a mayor player in the nanobio sector.
nAmbition is located in the Biotechnological Centre (BIOTEC) in Dresden and in the initial phase will employ more than 12 highly skilled scientists and engineers.